Junmei Cairns

6PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 01, 2021
CDC25B partners with PP2A to induce AMPK activation and tumor suppression in triple negative breast cancer.

Junmei Cairns, Reynold C Ly, Nifang Niu

|Feb 27, 2020
Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α.

James N Ingle, Junmei Cairns, Vera J Suman

|Jan 17, 2019
Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2.

Tanda M Dudenkov, Duan Liu, Junmei Cairns

|Jun 15, 2018
Principled multi-omic analysis reveals gene regulatory mechanisms of phenotype variation.

Casey Hanson, Junmei Cairns, Liewei Wang

|Jan 17, 2018
Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation.

Junmei Cairns, Brooke L Fridley, Gregory D Jenkins

|Oct 03, 2017
SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1.

Junmei Cairns, James N Ingle, Lawrence D Wickerham

Pageof 1

Frequent Collaborators

2 joint publications

Liewei Wang

2 joint publications

James N Ingle

1 joint publications

Casey Hanson

1 joint publications

Duan Liu